Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.4.0.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 432,881 $ 224,139
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 52,044 60,570
Asset impairment charges 1,396 1,698
Loss on extinguishment of debt and other, net 0 131,669
Non-cash stock-based compensation expense 32,758 43,098
Excess tax benefit from equity awards (12,176) (15,186)
Net gain on sales of marketable securities and other investments (4,105) (1,976)
Changes in assets and liabilities:    
Increase in accounts receivable, net (29,692) (162,234)
Decrease (increase) in inventories (93,976) 11,002
Decrease (increase) in other assets 4,659 (62,492)
Increase in accounts payable 22,956 700
Increase (decrease) in deferred system profit 44,528 (1,569)
Increase (decrease) in other liabilities (45,670) 59,008
Net cash provided by operating activities 405,603 288,427
Cash flows from investing activities:    
Capital expenditures, net (24,233) (36,554)
Proceeds from sale of assets 4,026 0
Purchases of available-for-sale securities (873,987) (1,433,856)
Proceeds from sale of available-for-sale securities 632,207 1,664,898
Proceeds from maturity of available-for-sale securities 472,437 564,283
Purchases of trading securities (48,248) (48,949)
Proceeds from sale of trading securities 51,738 50,558
Net cash provided by investing activities 213,940 760,380
Cash flows from financing activities:    
Proceeds from issuance of debt, net of issuance costs 0 3,224,906
Repayment of debt (95,000) (886,742)
Issuance of common stock 21,910 29,578
Tax withholding payments related to vested and released restricted stock units (23,723) (29,790)
Common stock repurchases (181,711) (435,030)
Payment of dividends to stockholders (265,163) (2,961,402)
Excess tax benefit from equity awards 12,176 15,186
Net cash used in financing activities (531,511) (1,043,294)
Effect of exchange rate changes on cash and cash equivalents (83) (14,482)
Net increase (decrease) in cash and cash equivalents 87,949 (8,969)
Cash and cash equivalents at beginning of period 838,025 630,861
Cash and cash equivalents at end of period 925,974 621,892
Supplemental cash flow disclosures:    
Income taxes paid, net 81,779 65,830
Interest paid 63,342 37,569
Non-cash activities:    
Purchase of land, property and equipment - investing activities 2,311 2,255
Unsettled common stock repurchase - financing activities 0 12,862
Dividends payable - financing activities $ 18,827 $ 41,412